Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Index by author

June 01, 1993; Volume 45,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Benfield, P

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

C

  1. Carini, D J

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;
  2. Chiu, A T

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

H

  1. Herblin, W F

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

J

  1. Janssen, L H

    1. You have access
      Recent research on the biological activity of suramin.
      T E Voogd, E L Vansterkenburg, J Wilting and L H Janssen
      Pharmacological Reviews June 1993, 45 (2) 177-203;

L

  1. Lee, R J

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

P

  1. Pucéat, M

    1. You have access
      Cardiac alpha 1-adrenoceptors: an overview.
      A Terzic, M Pucéat, G Vassort and S M Vogel
      Pharmacological Reviews June 1993, 45 (2) 147-175;

S

  1. Saye, J A

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;
  2. Smith, R D

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

T

  1. Terzic, A

    1. You have access
      Cardiac alpha 1-adrenoceptors: an overview.
      A Terzic, M Pucéat, G Vassort and S M Vogel
      Pharmacological Reviews June 1993, 45 (2) 147-175;
  2. Timmermans, P B

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;

V

  1. Vansterkenburg, E L

    1. You have access
      Recent research on the biological activity of suramin.
      T E Voogd, E L Vansterkenburg, J Wilting and L H Janssen
      Pharmacological Reviews June 1993, 45 (2) 177-203;
  2. Vassort, G

    1. You have access
      Cardiac alpha 1-adrenoceptors: an overview.
      A Terzic, M Pucéat, G Vassort and S M Vogel
      Pharmacological Reviews June 1993, 45 (2) 147-175;
  3. Vogel, S M

    1. You have access
      Cardiac alpha 1-adrenoceptors: an overview.
      A Terzic, M Pucéat, G Vassort and S M Vogel
      Pharmacological Reviews June 1993, 45 (2) 147-175;
  4. Voogd, T E

    1. You have access
      Recent research on the biological activity of suramin.
      T E Voogd, E L Vansterkenburg, J Wilting and L H Janssen
      Pharmacological Reviews June 1993, 45 (2) 177-203;

W

  1. Wexler, R R

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;
  2. Wilting, J

    1. You have access
      Recent research on the biological activity of suramin.
      T E Voogd, E L Vansterkenburg, J Wilting and L H Janssen
      Pharmacological Reviews June 1993, 45 (2) 177-203;
  3. Wong, P C

    1. You have access
      Angiotensin II receptors and angiotensin II receptor antagonists.
      P B Timmermans, P C Wong, A T Chiu, W F Herblin, P Benfield, D J Carini, R J Lee, R R Wexler, J A Saye and R D Smith
      Pharmacological Reviews June 1993, 45 (2) 205-251;
Back to top
PreviousNext

In this issue

Pharmacological Reviews
Vol. 45, Issue 2
1 Jun 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics